Katerina Scharov
Duesseldorf, NW 40225, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Deciphering the Therapeutic Potential of Novel Pentyloxyamide-Based Class I, IIb HDAC Inhibitors against Therapy-Resistant Leukemia.
Journal: Journal of medicinal chemistry
Published: November 27, 2024
High-throughput screening as a drug repurposing strategy for poor outcome subgroups of pediatric B-cell precursor Acute Lymphoblastic Leukemia.
Journal: Biochemical pharmacology
Published: May 05, 2023
mTORC1 regulates cell survival under glucose starvation through 4EBP1/2-mediated translational reprogramming of fatty acid metabolism.
Journal: Nature communications
Published: February 05, 2023
Definition and Prognostic Value of Ph-like and IKZF1plus Status in Children With Down Syndrome and B-cell Precursor Acute Lymphoblastic Leukemia.
Journal: HemaSphere
Published: October 04, 2022
EIF4EBP1 is transcriptionally upregulated by MYCN and associates with poor prognosis in neuroblastoma.
Journal: Cell death discovery
Published: January 19, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026